To include your compound in the COVID-19 Resource Center, submit it here.

Fast inflections

Why Longitude Capital joined Cydan's investor syndicate

Longitude Capital joined Cydan Development Inc.’s syndicate with the expectation that spinouts from the rare disease accelerator can deliver returns within three to five years.

The company sources rare disease assets from academia, not-for-profits and industry and funds preclinical

Read the full 397 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers